title: Pharmacokinetics of disodium fosfomycin in broilers and dose strategies to comply with its pharmacodynamics versus Escherichia coli.
abstract: The objective of this study was to determine, in broilers, which modality of disodium fosfomycin (DF) administration and at what dose the best pharmacokinetic (PK) profile could be obtained, taking as reference a 110 field bacterial strains of Escherichia coli minimum inhibitory concentration survey. The DF was administered via drinking water either ad libitum or at a higher concentration having 1 h of water restriction to build up thirst in the birds (loading dose). Dosages tested were 10, 20, 40, and 80 mg/kg per administration, either once or twice daily. Birds included were 24-d-old Cornish broilers randomly assigned to 16 groups of 200 birds per group and 3 replicates per group. The PK of DF was determined after ad libitum administration of either a single- or double-loading dose or after an initial loading dose followed by ad libitum medication. Also, PK after i.v. administration was studied in separate groups. Serial blood samplings were performed in all groups. Serum obtained was analyzed for DF and a possible active metabolite by means of a microbiological agar diffusion assay. The DF showed a short elimination half-life (approximately 2 h after oral loading administration) with a rapid clearance (1.23 to 1.42 mL/kg per h). Apparent volume of distribution-area under the curve values were also low (10 and 80 mg/kg=0.25 L/kg and 0.22 L/kg, respectively). Considering a minimum inhibitory concentration level that inhibited 90% of total strains of 8 µg/mL for E. coli, it is concluded that single-loading administration at 10, 20, 40, and 80 mg/kg complies poorly with sustained serum concentrations over a dosing interval of 24 h. Doses of 10 and 20 mg/kg twice a day also were insufficient to attain therapeutic concentrations. Useful serum concentrations of DF to treat outbreaks of susceptible E. coli require an initial loading dose of 40 mg/kg, followed by an ad libitum medication of 40 mg/kg 8 h later (80 mg/kg per d).
authors.affiliation: Departamento de Fisiología y Farmacología, Facultad de Medicina Veterinaria y Zootecnia, Ciudad de México, Mexico.
authors.forename: L
authors.initials: L
authors.lastname: Gutierrez
authors.forename: L
authors.initials: L
authors.lastname: Ocampo
authors.forename: C
authors.initials: C
authors.lastname: Rosario
authors.forename: H
authors.initials: H
authors.lastname: Sumano
mesh_terms: D000818:Animals; D019540:Area Under Curve; D002645:Chickens; D004305:Dose-Response Relationship, Drug; D004926:Escherichia coli / Q000187:drug effects*; D004927:Escherichia coli Infections / Q000517:prevention & control / Q000662:veterinary*; D005578:Fosfomycin / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use*; D006207:Half-Life; D008826:Microbial Sensitivity Tests; D011201:Poultry Diseases / Q000517:prevention & control*; D011485:Protein Binding; D013997:Time Factors
chemical_list: D005578:Fosfomycin